skeletonized internal mammary artery

骨骼化乳内动脉
  • 文章类型: Meta-Analysis
    目的:分析了糖尿病患者的双侧乳内动脉(BIMA)与单个乳内动脉(SIMA)的数据;这是唯一的荟萃分析,过去的7年。
    方法:Medline通过PubMed/EMBASE/CINHAL和Cochrane中央对照试验注册;研究了179篇文章;19项研究认为合适并纳入分析。
    结果:BIMA的死亡率为2.41%,SIMA为1.71%(比值比[OR]=0.95;95%置信区间[CI]:0.74-1.22)。BIMA术后再次出血的发生率较高,为3.75%,而SIMA为2.91%(OR=1.49;95%CI:1.15-1.93)。BIMA的MI发生率为0.87%,SIMA为0.83%(OR=0.73;95%CI:0.37-1.44)。胸骨深部伤口感染BIMA为3.02%,SIMA为1.95%(OR=1.57;95%CI:1.26-1.95)。当骨架化的时候,DSWI的发生率BIMA为2.5%,SIMA为2.41%.有利于BIMA的5年生存率存在显着差异,BIMA为85.15%,SIMA为80.77%(OR=1.79;95%CI:1.60-2.01)。10年总生存率为74.04%BIMA和61.57%SIMA(OR=1.79;95%CI:1.61-1.98)。BIMA的15年生存率为47.08%,SIMA为37.06%(OR=1.69;95%CI:1.52-1.88)。
    结论:BIMA组术后出血较高。糖尿病患者的双侧乳内动脉应以骨骼化的方式进行,减少DSWI。在手术后5年内,在糖尿病患者中使用BIMA具有生存益处;直到15年,它仍然很重要。
    OBJECTIVE: Data on bilateral internal mammary artery (BIMA) versus single internal mammary artery (SIMA) on diabetics were analyzed; This is the only meta-analysis, the last 7 years.
    METHODS: Medline through PubMed/EMBASE/CINHAL and the Cochrane Central Register of Controlled Trials; 179 articles were studied; 19 studies deemed suitable and were included in the analysis.
    RESULTS: The mortality was 2.41% for BIMA versus 1.71% for SIMA (odds ratio [OR] =  0.95; 95% confidence interval [CI]: 0.74-1.22). Postoperative reopening for bleeding was higher at 3.75% for BIMA versus 2.91% for SIMA (OR =  1.49; 95% CI: 1.15-1.93). The incidence of MI was 0.87% for BIMA versus 0.83% for SIMA (OR =  0.73; 95% CI: 0.37-1.44). Deep sternal wound infection was 3.02% for BIMA and 1.95% for SIMA (OR =  1.57; 95% CI: 1.26-1.95). When skeletonized, the incidence of DSWI was 2.5% for BIMA versus 2.41% for SIMA. There was a significant difference at 5-year survival favoring the BIMA, 85.15% BIMA versus 80.77% SIMA (OR =  1.79; 95% CI: 1.60-2.01). The 10-year overall survival was 74.04% BIMA versus 61.57% SIMA (OR =  1.79; 95% CI: 1.61-1.98). The 15-year survival was 47.08% for BIMA versus 37.06% for SIMA (OR =  1.69; 95% CI: 1.52-1.88).
    CONCLUSIONS: Postoperative bleeding was higher in BIMA group. Bilateral internal mammary artery in diabetic patients should be carried out in a skeletonize fashion, to reduce DSWI. There is a survival benefit of using BIMA in diabetics within 5 years of surgery; it remains significant up to 15 years.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Review
    目的:在本文中,我们报道了有关骨骼化双侧乳内动脉(BIMA)流量和对胸骨灌注的影响的最新文献.我们还回顾了骨骼化技术与传统椎弓根技术的优缺点。
    方法:我们使用PubMed数据库进行了最新的审查,特别关注当代出版的文学作品。
    结果:BIMA骨骼化可以保持胸骨微循环,最小化组织损伤,并在组织水平上维持胸壁的血液供应。这种效应在糖尿病患者中也是明显的。与传统的椎弓根技术相比,骨骼化的深部胸骨伤口感染(DSWI)率显着降低,并且与单乳内动脉采集相当。
    结论:当代大规模研究表明,BIMA的骨架化增加了导管长度,提供卓越的流量,减少DSWIs的发生率,并提高后期生存率。希望,本综述将提高对支持使用骨骼化乳内动脉和刺激增加BIMA血运重建手术摄取的有力证据的认识.
    OBJECTIVE: In this article, we reported on the up-to-date literature regarding skeletonized bilateral internal mammary artery (BIMA) flow and the effect on sternal perfusion. We also reviewed the pros and cons of the skeletonization technique versus the conventional pedicle technique for harvesting the BIMA.
    METHODS: We performed an up-to-date review using the PubMed database, with a specific focus on the contemporary published literature.
    RESULTS: BIMA skeletonization can preserve the sternal microcirculation, minimize tissue damage, and maintain blood supply to the chest wall at the tissue level. This effect is also apparent in diabetics. Deep sternal wound infection (DSWI) rates are significantly less with skeletonization versus the conventional pedicle technique and are comparable to single internal mammary artery harvesting.
    CONCLUSIONS: Contemporary large-scale studies demonstrate that skeletonization of the BIMA increases conduit length, provides superior flow, reduces the incidence of DSWIs, and improves late survival. Hopefully, this review will increase awareness of the compelling evidence in favor of using skeletonized internal mammary arteries and stimulate increased uptake of BIMA revascularization surgery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    BACKGROUND: Arterial grafts had better mid-term and long-term patency than saphenous vein grafts in coronary artery bypass grafting (CABG). We summarized our experience with total arterial off-pump coronary artery bypass grafting (OPCAB) and assessed the early clinical results, surgical complications, and follow-up.
    METHODS: From January 2007 to May 2017, 508 coronary artery disease patients undergoing total arterial OPCAB were enrolled. Clinical features, approaches, outcomes of surgical treatments, and follow-up data of these patients were studied retrospectively. A total of 122 patients underwent single left internal mammary artery (IMA)-left anterior descending artery grafts, whereas the other 386 patients underwent multiple vessel grafts.
    RESULTS: The average distal anastomosis was 2.34 ± 0.97 (range: 1-4). All the patients were discharged from hospital except one died. A total of 457 (90.32%) patients were followed up. In the 4-, 7-, and 10-year follow-up groups, the rate of death from any cause was 1.19%, 6.47%, and 10.67%; rate of cardiac death was 0.60%, 2.88%, and 3.33%; rate of repeat revascularization was 0.00%, 3.60%, and 8.67%; rate of ischemic symptoms was 1.79%, 7.91%, and 11.33%; and incidence of stroke was 2.38%, 4.32%, and 6.67%, respectively. Poor medication adherence was observed in 9.38% of the follow-up population.
    CONCLUSIONS: Total arterial OPCAB with bilateral IMA, radial artery, and right gastroepiploic artery grafting yielded satisfactory early and midterm outcomes in this patient group, without a significant increase in early mortality or morbidity. Moreover, the long-term outcomes are also positive.
    全动脉化非体外循环冠状动脉旁路移植术10年经验摘要背景: 背景 冠状动脉旁路移植术中静脉桥中远期通畅率不理想催生了动脉桥的应用。总结全动脉化非体外循环冠状动脉旁路移植术(OPCAB)的临床应用经验,并观察早期临床结果、手术并发症及随访结果。 方法: 从2007年1月至2017年5月,共完成了508例全动脉化OPCAB,回顾总结这些患者的临床特点、手术方式、手术效果及随访资料。其中122例患者单纯行左乳内动脉-前降支搭桥,其余386例患者行多支血管吻合。 结果: 平均远端吻合口2.34±0.97 (1-4),院内死亡1例,其余患者均痊愈出院。随访457(90.32%)例患者,4,7,10年随访组全因死亡率分别为1.19%,6.47%及10.67%;心源性死亡率分别为0.60%,2.88%和3.33%;再血管化率分别为0.00%,3.60%和8.67%;再发缺血症状分别为1.79%,7.91%和11.33%;脑卒中发生率分别为2.38%,4.32%及6.67%。9.38%随访人群未正规服用冠心病二级预防药物。 结论: 应用双侧乳内动脉、桡动脉及胃网膜右动脉进行全动脉化搭桥的此组患者,在未增加早期死亡率及并发症的情况下,得到了满意的早期及中期结果,另外,也有令人满意的晚期结果。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Editorial
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号